Notis McConarty Edward Takes $4.54 Million Position in Danaher Corporation $DHR

Notis McConarty Edward purchased a new position in shares of Danaher Corporation (NYSE:DHRFree Report) during the second quarter, HoldingsChannel reports. The firm purchased 23,856 shares of the conglomerate’s stock, valued at approximately $4,544,000. Danaher makes up about 2.0% of Notis McConarty Edward’s portfolio, making the stock its 20th biggest holding.

Other large investors have also added to or reduced their stakes in the company. Main Street Group LTD bought a new stake in shares of Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter worth $25,000. JPL Wealth Management LLC bought a new position in Danaher in the 3rd quarter valued at about $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the 4th quarter valued at approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $216.14 on Friday. The company has a market cap of $151.94 billion, a P/E ratio of 38.39, a PEG ratio of 2.63 and a beta of 0.78. The business has a 50-day moving average price of $195.01 and a two-hundred day moving average price of $192.43. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the business earned $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on DHR shares. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Guggenheim decreased their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Stifel Nicolaus reduced their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Read Our Latest Analysis on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.